FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for duloxetine (ANDA204343), enabling the continued marketing of the generic product. This rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Musculoskeletal Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE)